123 results on '"Advani, Pooja"'
Search Results
2. Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
3. Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
4. Updates in prognostication and treatment of Waldenström’s macroglobulinemia
5. Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial
6. Abstract P4-01-22: Clinical outcomes of metastatic breast cancer patients treated with poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPi): the Mayo Clinic experience
7. Abstract P3-05-25: Clinical Factors associated with Survival Outcomes in Patients with Metaplastic Breast Cancer
8. Abstract P4-01-17: Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
9. Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study
10. FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma
11. Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer
12. HOME CARDIAC SURVEILLANCE WITH ARTIFICIAL INTELLIGENCE DIGITAL PATIENT MONITORING DURING TREATMENT WITH PERTUZUMAB, TRASTUZUMAB AND HYALURONIDASE-ZZXF FOR HER2-POSITIVE BREAST CANCER (HARRIET): STUDY DESIGN AND RATIONALE
13. Abstract P2-11-15: Clinical trial enrollment for initial therapy of breast cancer: Exploring factors associated with poor accrual and significant disparities
14. Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination
15. Abstract P5-14-16: Factors associated with endocrine therapy refusal in hormone receptor-positive breast cancer patients
16. Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients
17. A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
18. Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure
19. Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect
20. HER2 testing across practices-Have we come to a consensus on the ideal method of testing? A systematic literature review
21. WITHDRAWN: Updates in Prognostication and Treatment of Waldenström’s Macroglobulinemia
22. Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure
23. Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia
24. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
25. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis
26. Racial Disparity in Drug Utilization Among Multiple Myeloma Patients: A SEER Medicare Analysis
27. Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)
28. WITHDRAWN: Updates in Prognostication and Treatment of Waldenström’s Macroglobulinemia
29. Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors
30. Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma
31. Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
32. Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma
33. Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)
34. T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Presenting as a Primary Central Nervous System Lymphoma
35. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.
36. Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
37. Abstract 4761: Characterization of individual foci of multifocal invasive lobular breast cancer using gene expression profiling
38. Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications
39. HER2 testing and its predictive utility in anti-HER2 breast cancer therapy
40. Current strategies for the prevention of breast cancer
41. Current State of Patient Awareness and Participation in Care for Multiple Myeloma and the Psychophysical Impact of Treatment: An International Internet-Based Study
42. Current strategies for the prevention of breast cancer
43. BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy
44. Preclinical Evaluation of the Proteasome Inhibitor MLN9708 (MLN2238) In Chronic Lymphocytic Leukemia Cells
45. The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy
46. Behavioral Patterns and the Role of Ethnicity in Patient Awareness of Multiple Myeloma and the Psychophysical Impact of Its Treatment
47. Current strategies for the prevention of breast cancer.
48. Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia
49. Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer.
50. Current strategies for the prevention of breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.